Halozyme Therapeutics
HALO
#1489
Rank
C$20.35 B
Marketcap
C$179.38
Share price
1.89%
Change (1 day)
94.67%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2026 (TTM): C$0.82 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are C$1.66 Billion. In 2025 the company made an earning of C$0.65 Billion a decrease over its 2024 earnings that were of C$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$0.82 B25.67%
2025 C$0.65 B-16.2%
2024 C$0.78 B59.94%
2023 C$0.48 B39.94%
2022 C$0.34 B0.16%
2021 C$0.34 B92.2%
2020 C$0.18 B-278.96%
2019 -C$0.11 Billion-9.45%
2018 -C$0.12 Billion-229.51%
2017 C$86.33 M-160.48%
2016 -C$0.15 Billion216.03%
2015 -C$45.17 Million-52.86%
2014 -C$95.82 Million-18.09%
2013 -C$0.12 Billion55.88%
2012 -C$75.05 Million169.94%
2011 -C$27.81 Million-63.44%
2010 -C$76.04 Million-7.19%
2009 -C$81.92 Million15.91%
2008 -C$70.68 Million83.89%
2007 -C$38.44 Million78.1%
2006 -C$21.59 Million16%
2005 -C$18.61 Million45.24%
2004 -C$12.81 Million682.42%
2003 -C$1.64 Million1659.12%
2002 -C$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.72 B 4,392.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$9.67 B 1,084.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$47.07 B 5,659.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.03 B 1,127.47%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-C$0.68 Billion-182.80%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-C$68.19 Million-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA